Selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (DRL), without physical withdrawal symptoms, and who do not require immediate detoxification. Selincro should only be prescribed in conjunction with continuous psycho-social support focused on treatment adherence and reducing alcohol consumption. Selincro should be initiated only in patients with a high DRL two weeks after the initial assessment.
The most common side effects may include the following:
- Dizziness
- Headache
- Trouble sleeping
- Feeling sick (vomiting and nausea)
- Confusion
- Loss of appetite that may result in weight loss
- Drowsiness
- Decreased sex drive
- Pins and needles sensation
- Racing of the heart or irregular heartbeats
- Excessive sweating
- Weakness
Selincro’s uncommon and rare side effects are not listed here. For further information, refer to the manufacturer’s product insert included with this medication.
Consult with a doctor or healthcare provider before using this medication.
Selincro is indicated for the treatment of patients with alcohol dependence. Alcohol dependence is defined as drinking more than a certain amount of pure alcohol per day. The amount for women is 40 grams, and for men, 60 grams.